These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 8458600)
1. Experimental models of torsades de pointes. Weissenburger J; Davy JM; Chézalviel F Fundam Clin Pharmacol; 1993; 7(1):29-38. PubMed ID: 8458600 [TBL] [Abstract][Full Text] [Related]
2. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633 [TBL] [Abstract][Full Text] [Related]
3. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. Eckardt L; Haverkamp W; Mertens H; Johna R; Clague JR; Borggrefe M; Breithardt G J Cardiovasc Pharmacol; 1998 Sep; 32(3):425-34. PubMed ID: 9733356 [TBL] [Abstract][Full Text] [Related]
4. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502 [TBL] [Abstract][Full Text] [Related]
5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR; Yan GX; Gallacher DJ J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247 [TBL] [Abstract][Full Text] [Related]
6. Combination of sotalol and quinidine in a canine model of torsades de pointes: no increase in the QT-related proarrhythmic action of sotalol. Chézalviel-Guilbert F; Deplanne V; Davy JM; Poirier JM; Xia YZ; Cheymol G; Weissenburger J J Cardiovasc Electrophysiol; 1998 May; 9(5):498-507. PubMed ID: 9607458 [TBL] [Abstract][Full Text] [Related]
7. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644 [TBL] [Abstract][Full Text] [Related]
8. A canine model of torsades de pointes. Leichter D; Danilo P; Boyden P; Rosen TS; Rosen MR Pacing Clin Electrophysiol; 1988 Dec; 11(12):2235-45. PubMed ID: 2463611 [TBL] [Abstract][Full Text] [Related]
9. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation. Lu HR; Remeysen P; De Clerck F J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372 [TBL] [Abstract][Full Text] [Related]
10. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome. Johansson M; Carlsson L J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331 [TBL] [Abstract][Full Text] [Related]
11. [Experimental models of torsades de pointes]. Davy JM; Weissenburger J; Chezalviel F; Ertzbischoff O Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():15-21. PubMed ID: 1307190 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation. Eckardt L; Breithardt G; Haverkamp W J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098 [TBL] [Abstract][Full Text] [Related]
13. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe. D'Alonzo AJ; Zhu JL; Darbenzio RB Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682 [TBL] [Abstract][Full Text] [Related]
14. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes. Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874 [TBL] [Abstract][Full Text] [Related]
15. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms. Morganroth J Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias. Kühlkamp V; Mermi J; Mewis C; Seipel L J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model. Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block. Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823 [TBL] [Abstract][Full Text] [Related]
19. Apamin induces early afterdepolarizations and torsades de pointes ventricular arrhythmia from failing rabbit ventricles exhibiting secondary rises in intracellular calcium. Chang PC; Hsieh YC; Hsueh CH; Weiss JN; Lin SF; Chen PS Heart Rhythm; 2013 Oct; 10(10):1516-24. PubMed ID: 23835258 [TBL] [Abstract][Full Text] [Related]
20. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes. Farkas A; Leprán I; Papp JG J Cardiovasc Pharmacol; 2002 Feb; 39(2):287-97. PubMed ID: 11791015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]